Industry: Animal Health

Animal health industry funding

Animal health investors back products with a clear licence route and a farmer or vet ready to pay. Waveup helps you prove both with your trial data, farm economics and likely partners.

  • Market figures and investor lists covering vet medicines, diagnostics and livestock health
  • Decks and models built around licensing steps, field trials and farm payback
  • Waveup prepares investor materials for animal health companies: $3B+ raised for 600+ startups since 2014

In short

What is animal health industry funding?

Animal health industry funding is the capital raised by companies that make veterinary medicines, vaccines, diagnostics and livestock health tools. Angels, specialist VCs, corporate venture arms, private equity and grant programmes all provide it. The 20 largest animal health companies took in $38.6B in 2024. Most exits are a sale or licence to one of them.

Who it's for
Veterinary medicine, vaccine, diagnostics and livestock health companies, pre-seed to Series D+
What we build
Investor deck, financial model, valuation, investor list, data room
Track record
$3B+ raised for 600+ startups since 2014

Market data checked on 6 November 2026. Sources are under each section.

Why do investors back animal health in 2026?

Because disease keeps costing farmers money, and prevention is where sales grow. But the market is small and the buyers are few, so investors want proof early.

The opportunity

Outbreaks, food demand and pressure on antibiotics all create buyers for new products.

  • Bird flu reached US dairy herds in 2024, and screwworm was confirmed in Texas and Arizona in October 2026
  • USDA offered up to $100M for new screwworm tools through a Grand Challenge, now closed
  • Elanco is launching a venture fund for pre-seed to Series A companies

The problem

Animal health is short of money. WOAH says it receives as little as 0.6% of global health spending.

Market size

How big is the animal health industry, and what drives it?

The 20 largest animal health companies took in $38.6B in 2024, S&P Global counts. Four forces shape where new money goes:

  • Prevention: vaccines and parasiticides made up 60% of animal health sales in 2024
  • Disease: animal diseases destroy more than 20% of global animal production each year
  • Food demand: OECD and FAO expect poultry meat consumption to grow 21% by 2034
  • Research: HealthforAnimals members invested $13.8B in R&D from 2020 to 2025
Share of worldwide animal health sales: vaccines 25.7% in 2013 and 28.4% in 2022; antimicrobials 20.9% and 12.7%.

Animal health in 2026, in six numbers

€9.6B

of animal medicine sales across Europe in 2025, the second-largest market worldwide

$797M

of livestock sales at Zoetis in Q3 2026, up 7% on a year earlier

$358B+

is what disease costs livestock producers worldwide each year, HealthforAnimals estimates

75%

of emerging human infectious diseases have an animal origin, WOAH says

74

human cases of H5 bird flu in the US since February 2024

109

new animal vaccines delivered by HealthforAnimals members from 2020 to 2025

Venture capital

Is there venture money for animal health startups?

There is no public yearly total for animal health venture funding, and rounds are small. Money comes from agrifood funds, biotech investors and corporate venture arms, while the big animal health companies license and buy.

Livestock sales in 2025: Merck Animal Health $3.9B, Zoetis $2.8B and Elanco $2.4B.
$25M

committed by Elanco over several years to Elanco Ventures, for pre-seed to Series A companies

Nearly $1B

of venture funding went into livestock health monitoring in the five years to 2025, Lux Research counts

$1.3B

paid by Merck in 2024 for Elanco's aqua business, with its fish vaccines and two plants

Who invests in animal health startups?

Animal health angels, agrifood VCs, life sciences funds, strategic buyers, private equity and US grants. One example of each; for more agriculture investors, see our list of agriculture venture capital firms.

Investor
Type and base
Animal health companies backed
Stage or cheque
VANE (Veterinary Angel Network for Entrepreneurs)
Angel network for animal health only, US
GenVax, Dalan Animal Health, MI:RNA
Early stage; 40+ companies backed since 2021
Anterra Capital
Agrifood and animal health VC, Boston and Amsterdam
BiomEdit, Invetx (both shown as exited), Native Microbials
Seed or Series A; first cheque $1M to $10M
Seventure Partners
Life sciences and tech VC, Paris
ViroVet, NovoBind, CattleEye
Seed to late stage; €1M to €10M a round
Merck Animal Health
Animal health arm of Merck, Rahway (NJ)
Elanco's aqua business (bought 2024); runs Allflex livestock monitoring
Acquisitions
EQT
Global private markets firm, Sweden
Dechra, a UK vet medicines maker taken private in 2024
Buyouts (EQT X fund)
USDA NIFA SBIR
US federal grants, topic 8.3 Animal Production and Protection
Small businesses working on disease detection, treatment and prevention
Phase I up to $175K; Phase II up to $600K

Investor database

Agtech investors in our database

The funds with the most agtech investments. Pick a stage, or open a fund for its cheque sizes.

Top 5 by agtech investments

  • Investments by industry

    • Agritech & Farming24%
    • Software & Apps14%
    • AI & Deep Tech11%
    Rounds
    SeedSeries ASeries BSeries C+
    Average cheque
    $500K–$1M$1M–$3M$3M–$10M
    Based in
    India
    Invests in
    South Asia

    128 investments in total, 21 tagged Agritech & Farming.Open the full fund profile

  • Investments by industry

    • Healthtech & Wellness25%
    • Software & Apps23%
    • Agritech & Farming12%
    Rounds
    SeedSeries ASeries BSeries C+
    Average cheque
    $1M–$3M$3M–$10M$10M–$50M
    Based in
    Chicago, USA
    Invests in
    USA

    214 investments in total, 15 tagged Agritech & Farming.Open the full fund profile

  • Investments by industry

    • Agritech & Farming17%
    • Energy & Utilities14%
    • Healthtech & Wellness11%
    Rounds
    SeedSeries ASeries BSeries C+
    Average cheque
    $500K–$1M$1M–$3M$3M–$10M
    Based in
    Chicago, United States
    Invests in
    USA

    171 investments in total, 13 tagged Agritech & Farming.Open the full fund profile

  • Investments by industry

    • Agritech & Farming20%
    • Energy & Utilities18%
    • CleanTech & Sustainability12%
    Rounds
    SeedSeries ASeries BSeries C+
    Average cheque
    $0–$100K$100K–$500K$500K–$1M
    Based in
    Beverly Hills, United States
    Invests in
    USA

    27 investments in total, 10 tagged Agritech & Farming.Open the full fund profile

  • Investments by industry

    • Agritech & Farming21%
    • Software & Apps17%
    • Hardware. Robotics & IoT14%
    Rounds
    Pre-seedSeedSeries A
    Average cheque
    $0–$100K$100K–$500K$500K–$1M$1M–$3M$3M–$10M
    Based in
    San Francisco, United States
    Invests in
    USA

    126 investments in total, 9 tagged Agritech & Farming.Open the full fund profile

From our investor database.

What slows down an animal health raise?

Our Fundraising 2025 study asked 56 VCs why they turn founders down. Revenue growth, unit economics, burn and missed milestones led the list, with defensibility and crowded categories next. Animal health has its own version of each.

Small markets per product

Animal medicines are a niche next to human drugs. In Europe, they are worth about 3% of the human pharmaceutical market.

What investors ask

  • How big can one product get, across species and countries?

What your deck shows

  • Sales potential by species, country and buyer
  • A platform that leads to a second product

Licences take years and cash

New medicines, vaccines and biologics need FDA, USDA or EMA approval before the first sale. BiomEdit raised about $18.4M in 2025 to carry it through USDA licensing and into launch.

What investors ask

  • Which agency licenses your product, and when can you sell it?

What your deck shows

  • Your licence route, step by step, with dates
  • Cash to reach the licence and first sales

Farmers buy on payback

A livestock product sells only if it earns back its cost in growth, milk or lower losses. Products that cut the need for antibiotics lag: HealthforAnimals members delivered 19 of a planned 30 by 2025.

What investors ask

  • After paying for your product, what does a farmer gain per animal?

What your deck shows

  • Field-trial results in money per animal
  • Your price against what farmers use today

Demand that follows outbreaks

An outbreak creates sudden demand, then policy decides who buys. Nearly 1,000 US dairy herds caught H5N1 bird flu between March 2024 and February 2025.

What investors ask

  • Will sales hold up once the outbreak is under control?

What your deck shows

  • Demand that doesn't rest on one outbreak
  • Who pays: farmers, vets or governments

How we help you raise

Flat fees agreed before we start. No success fee on advisory work.

    From $6,000

    Licence route, field data and farm payback, in plain words.

    From $3,000

    Licensing costs, launch timing and sales by species, month by month.

    From $5,000

    A range set against animal health deals and licensing terms.

    Agrifood funds, corporate venture arms and grants that fit your stage.

    Trial data, regulatory files and manufacturing records, ready to review.

    For a sale or licensing deal with an animal health company.

Who we are

Waveup is a London-based fundraising and growth advisory, working in 60+ countries and 90+ industries. Since 2014 we have built the decks, models, CIMs and valuations behind $3B+ raised for 600+ startups.

About us
Track record
$3B+
raised for 600+ startups
Decks
1,000+
decks since 2014
M&A
50+
M&A transactions supported, including 20+ exits
Reach
60+
countries, across 90+ industries

Animal health industry funding FAQ

Who invests in animal health startups?
VANE, a US angel network, backs only animal health startups. Agrifood and animal health VCs such as Anterra Capital invest at seed and Series A. Life sciences funds such as Seventure Partners back vaccines and biologics. Animal health companies invest as well: Elanco Ventures launches in late 2026. Private equity buys established firms, as EQT did with Dechra. Grants such as USDA's SBIR programme fund early research. See how corporate venture capital differs before taking a strategic investor's money.
How do animal health startups get funding?
Who is the largest animal health company?
What do investors look for in an animal health startup?
How big is the animal health market?
How much does help with an animal health raise cost?

Industries we work with

Agriculture and Farming

All industries

Raising for an animal health company?

Send us your product, the species it serves and your next licensing step. We'll point out what investors are likely to test first.

Have a project in mind?

Leave your information below and one of our experts will be in touch to schedule a call.

Your name:
*Your email:
*You need help with:
Your project is:
Your current stage:
Your maximum budget:
How did you find us?